Publications found:
369
Sort by:
Global Erythropoietin Drugs Market - 2024-2032
US$ 2,999.00
The Global Erythropoietin Drugs Market was valued at US$ 10.77 billion in 2024 and is anticipated to reach US$ 14.59 billion by 2032, at a CAGR of 0.079 from 2026 to 2032. The report delivers in-depth...
July 2025
218 pages
Janus Kinase (JAK) Inhibitors Market - 2024-2033
US$ 2,999.00
The Janus Kinase (JAK) Inhibitors Market was valued at US$ 15.56 billion in 2024 and is anticipated to reach US$ 30.65 billion by 2033, at a CAGR of 0.068 from 2026 to 2032. The report delivers in-dep...
July 2025
210 pages
U.S. Anti-Venom Market Size, Share & Trends Analysis Report By Species (Snake, Scorpion, Spider), By Type (Polyvalent, Monovalent), By Mode of Action (Cytotoxic, Neurotoxic), By End Use, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within 2 Business Days U.S. Anti-Venom Market The U.S. anti-venom market size was estimated at USD 424.5 million in 2024 and is projected to reach USD 670...
July 2025
80 pages
Humira Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Branded, Biosimilar), By Application (Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Crohn’s Disease (CD), Ulcerative Colitis (UC), Ankylosing Spondylitis, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region and Competition, 2020-2030F
US$ 4,500.00
Market Overview The Global Humira Market was valued at USD 10.41 Billion in 2024 and is projected to reach USD 19.84 Billion by 2030, growing at a CAGR of 11.32% during the forecast period. The market...
July 2025
184 pages
Adalimumab Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Biologics, Biosimilars), By Therapeutic Area (Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis, Crohn’s Disease, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
Market Overview The Global Adalimumab Market was valued at USD 2.72 billion in 2024 and is anticipated to reach USD 3.56 billion by 2030, growing at a CAGR of 4.80% over the forecast period. Adalimuma...
June 2025
185 pages
Immunotherapy Drugs Market - 2024-2033
US$ 2,999.00
The Immunotherapy Drugs Market was valued at US$ 288.02 Billion in 2024 and is anticipated to reach US$ 872.64 Billion by 2033, at a CAGR of 0.132 from 2026 to 2032. The report delivers in-depth insig...
May 2025
200 pages
Asia Pacific Biologics Market Forecast to 2031 - Regional Analysis - by Product (Monoclonal Antibodies, Vaccine, Recombinant Hormones/Proteins, Cell and Gene Therapy, and Others), Application (Cancer, Infectious Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), and Manufacturing (Outsourced and In-house)
US$ 3,450.00
The Asia Pacific biologics market was valued at US$ 1,01,590.5 million in 2023 and is expected to reach US$ 4,17,082.9 million by 2031; it is estimated to register a CAGR of 19.3% from 2023 to 2031. E...
April 2025
163 pages
Europe Biologics Market Forecast to 2031 - Regional Analysis - by Product (Monoclonal Antibodies, Vaccine, Recombinant Hormones/Proteins, Cell and Gene Therapy, and Others), Application (Cancer, Infectious Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), and Manufacturing (Outsourced and In-house)
US$ 3,450.00
The Europe biologics market was valued at US$ 1,15,057.6 million in 2023 and is expected to reach US$ 4,15,468.4 million by 2031; it is estimated to register a CAGR of 17.4% from 2023 to 2031. Prefere...
April 2025
162 pages
Middle East & Africa Biologics Market Forecast to 2031 - Regional Analysis - by Product (Monoclonal Antibodies, Vaccine, Recombinant Hormones/Proteins, Cell and Gene Therapy, and Others), Application (Cancer, Infectious Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), and Manufacturing (Outsourced and In-house)
US$ 3,450.00
The Middle East & Africa biologics market was valued at US$ 5,818.6 million in 2023 and is expected to reach US$ 17,939.1 million by 2031; it is estimated to register a CAGR of 15.1% from 2023 to 2031...
April 2025
153 pages
North America Biologics Market Forecast to 2031 - Regional Analysis - by Product (Monoclonal Antibodies, Vaccine, Recombinant Hormones/Proteins, Cell and Gene Therapy, and Others), Application (Cancer, Infectious Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), and Manufacturing (Outsourced and In-house)
US$ 3,450.00
The North America biologics market was valued at US$ 230,256.1 million in 2023 and is expected to reach US$ 888,880.0 million by 2031; it is estimated to register a CAGR of 18.4% from 2023 to 2031. In...
April 2025
146 pages
South & Central America Biologics Market Forecast to 2031 - Regional Analysis - by Product (Monoclonal Antibodies, Vaccine, Recombinant Hormones/Proteins, Cell and Gene Therapy, and Others), Application (Cancer, Infectious Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), and Manufacturing (Outsourced and In-house)
US$ 3,450.00
The South & Central America biologics market was valued at US$ 16,517.2 million in 2023 and is expected to reach US$ 54,534.7 million by 2031; it is estimated to register a CAGR of 16.1% from 2023 to...
April 2025
139 pages
Immunoglobulins Market Size, Share, and Analysis, By Product Type (IgG, IgA, IgM, IgD, IgE, and Others), By Route of Administration (Intravenous (IVIG), Subcutaneous (SCIg), and Others), By Application (Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Multifocal Motor Neuropathy (MMN), Primary Immunodeficiency Disease (PID), Secondary Immunodeficiency Disease (SID), Guillain-Barre syndrome, Immune thrombocytopenic purpura (ITP), and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
US$ 5,250.00
Immunoglobulins Market Size, Share, and Analysis, By Product Type (IgG, IgA, IgM, IgD, IgE, and Others), By Route of Administration (Intravenous (IVIG), Subcutaneous (SCIg), and Others), By Applicatio...
February 2025
571 pages
Interleukin Inhibitors Market - 2024-2032
US$ 2,999.00
The Interleukin Inhibitors Market was valued at US$ 49.56 billion in 2024 and is anticipated to reach US$ 116.42 billion by 2032, at a CAGR of 0.085 from 2026 to 2032. The report delivers in-depth ins...
January 2025
207 pages
Autologous Stem Cell & Non-stem Cell Therapies Market Size, Share, and Analysis, By Type (Autologous Stem Cell Therapies and Autologous Non-stem Cell Therapies), By Application (Cancer Indications, Musculoskeletal Indications, Dermatological Indications, and Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Research Facilities, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
US$ 5,250.00
Autologous Stem Cell & Non-stem Cell Therapies Market is projected to exhibit a Compound Annual Growth Rate (CAGR) of 21% during the forecast span from 2024 to 2034. In 2023, the market size was asses...
January 2025
571 pages
Cell Therapy CDMO Market Size, Share, and Analysis, By Type (Stem Cell and Non-Stem Cell), By Application (Commercial and Academic Research), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
US$ 5,250.00
Cell Therapy CDMO Market is anticipated to exhibit a Compound Annual Growth Rate (CAGR) of 22.7% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 5.9 billion an...
January 2025
411 pages
Global CAR T Cell Therapy Market & Clinical Trials Insight 2028
US$ 3,000.00
... CAR T Cell Therapies Clinical Pipeline by Company, Indication & Phase Global CAR T Cell Therapies Clinical Pipeline: 99 Therapies CAR T Cell Therapies in Highest Phase: Preregistration Majority of CAR T Cell Therapies in Phase-I/II Trials: 16 Therapies Global Market Scenario of CAR T Cell Therapy Global CAR ...
May 2022
720 pages
